SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-095493
Filing Date
2023-12-14
Accepted
2023-12-14 06:21:04
Documents
3
Period of Report
2023-12-14

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea190037-6k_scinaiimmun.htm 6-K 13020
2 PRESS RELEASE, DATED DECEMBER 11, 2023 ea190037ex99-1_scinaiimmun.htm EX-99.1 15696
3 PRESS RELEASE, DATED DECEMBER 12, 2023 ea190037ex99-2_scinaiimmun.htm EX-99.2 22604
  Complete submission text file 0001213900-23-095493.txt   52522
Mailing Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000
Business Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000 972-8-9302529
Scinai Immunotherapeutics Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37353 | Film No.: 231485520
SIC: 2836 Biological Products, (No Diagnostic Substances)